Cargando…
(A Critical Appraisal of) Classification of Hypereosinophilic Disorders
Hypereosinophilia (HE) is a heterogeneous condition that can be reported in various (namely inflammatory, allergic, infectious, or neoplastic) diseases with distinct pathophysiological pathways. In 1975, Chusid et al. published the first diagnostic criteria of hypereosinophilic syndromes (HES). Over...
Autores principales: | Kahn, Jean Emmanuel, Groh, Matthieu, Lefèvre, Guillaume |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5723313/ https://www.ncbi.nlm.nih.gov/pubmed/29259972 http://dx.doi.org/10.3389/fmed.2017.00216 |
Ejemplares similares
-
Cutaneous manifestations of lymphoid‐variant hypereosinophilic syndrome
por: Laurent, Claire, et al.
Publicado: (2022) -
French guidelines for the etiological workup of eosinophilia and the management of hypereosinophilic syndromes
por: Groh, Matthieu, et al.
Publicado: (2023) -
Clinical and Biological Markers in Hypereosinophilic Syndromes
por: Khoury, Paneez, et al.
Publicado: (2017) -
Moderate-to-severe eosinophilia induced by treatment with immune checkpoint inhibitors: 37 cases from a national reference center for hypereosinophilic syndromes and the French pharmacovigilance database
por: Scanvion, Quentin, et al.
Publicado: (2020) -
Mepolizumab therapy improves the most bothersome symptoms in patients with hypereosinophilic syndrome
por: Roufosse, Florence, et al.
Publicado: (2023)